Mark F Mehler
Overview
Explore the profile of Mark F Mehler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
7539
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eligulashvili A, Gordon M, Lee J, Lee J, Mehrotra-Varma S, Mehrotra-Varma J, et al.
PLoS Med
. 2024 Apr;
21(4):e1004263.
PMID: 38573873
Background: Acute neurological manifestation is a common complication of acute Coronavirus Disease 2019 (COVID-19) disease. This retrospective cohort study investigated the 3-year outcomes of patients with and without significant neurological...
2.
Boparai M, Musheyev B, Hou W, Mehler M, Duong T
Front Neurol
. 2023 Oct;
14:1258352.
PMID: 37900601
Introduction: Neurocognitive symptoms and dysfunction of various severities have become increasingly recognized as potential consequences of SARS-CoV-2 infection. Although there are numerous observational and subjective survey-reporting studies of neurological symptoms,...
3.
Hickman R, OShea S, Mehler M, Chung W
Nat Rev Neurol
. 2022 Jan;
18(2):117-124.
PMID: 34987232
Intellectual disability and autism spectrum disorder (ASD) are common, and genetic testing is increasingly performed in individuals with these diagnoses to inform prognosis, refine management and provide information about recurrence...
4.
Anand H, Ende V, Singh G, Qureshi I, Duong T, Mehler M
Front Neurosci
. 2021 Sep;
15:727060.
PMID: 34512253
SARS-CoV-2 infection is associated with a spectrum of acute neurological syndromes. A subset of these syndromes promotes higher in-hospital mortality than is predicted by traditional parameters defining critical care illness....
5.
6.
Eskandar E, Altschul D, De La Garza Ramos R, Cezayirli P, Unda S, Benton J, et al.
Neurology
. 2021 Jan;
96(11):e1527-e1538.
PMID: 33443111
Objective: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is protean in its manifestations, affecting nearly every organ system. However, nervous system involvement and its effect on disease outcome are poorly...
7.
Galanopoulou A, McArthur D, Ferastraoaru V, Correa D, Cherian K, Duberstein S, et al.
Epilepsia Open
. 2020 Nov;
5(4):618-621.
PMID: 33230490
No abstract available.
8.
Biundo F, Chitu V, Shlager G, Park E, Gulinello M, Saha K, et al.
Glia
. 2020 Oct;
69(3):779-791.
PMID: 33079443
Adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is a dementia resulting from dominantly inherited CSF1R inactivating mutations. The Csf1r mouse mimics ALSP symptoms and pathology. Csf1r is...
9.
Geyer H, Kaufman D, Parihar R, Mehler M
Tremor Other Hyperkinet Mov (N Y)
. 2020 Sep;
10:25.
PMID: 32864184
No abstract available.
10.
Galanopoulou A, Ferastraoaru V, Correa D, Cherian K, Duberstein S, Gursky J, et al.
Epilepsia Open
. 2020 Jun;
5(2):314-324.
PMID: 32537529
Objective: Acute encephalopathy may occur in COVID-19-infected patients. We investigated whether medically indicated EEGs performed in acutely ill patients under investigation (PUIs) for COVID-19 report epileptiform abnormalities and whether these...